BN83495 Phase I in Post-menopausal Women

BN83495 in Prostate Cancer

An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.

An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in People With Fibrodysplasia Ossificans Progressiva (FOP) in France

An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)

Evaluation of Palovarotene Concentration in Semen of Healthy Men after Multiple Oral Doses

A Thorough QT Study Evaluating the Effect of a Therapeutic and a Supratherapeutic Dose of Palovarotene on Electrocardiogram Parameters

Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult Subjects

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel